{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:34:16Z","timestamp":1759541656800,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00204-010-0530-z","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T09:54:35Z","timestamp":1268214875000},"page":"597-607","source":"Crossref","is-referenced-by-count":7,"title":["Combined ascorbate and glutathione deficiency leads to decreased cytochrome b 5 expression and impaired reduction of sulfamethoxazole hydroxylamine"],"prefix":"10.1007","volume":"84","author":[{"given":"Sachin","family":"Bhusari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Abouraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia L.","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie E.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Drescher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Trepanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"530_CR1","first-page":"36","volume":"11","author":"MD Abramoff","year":"2004","unstructured":"Abramoff MD, Magalhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics Int 11:36\u201343","journal-title":"Biophotonics Int"},{"key":"530_CR2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ajcn\/72.3.809","volume":"72","author":"JD Bogden","year":"2000","unstructured":"Bogden JD, Kemp FW, Han S, Li W, Bruening K, Denny T, Oleske JM, Lloyd J, Baker H, Perez G, Kloser P, Skurnick J, Louria DB (2000) Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr 72:809\u2013815","journal-title":"Am J Clin Nutr"},{"key":"530_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00002030-199403000-00006","volume":"8","author":"A Carr","year":"1994","unstructured":"Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA (1994) Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. Aids 8:333\u2013337","journal-title":"Aids"},{"key":"530_CR4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1124\/mol.107.043273","volume":"73","author":"L Cheng","year":"2008","unstructured":"Cheng L, Stewart BJ, You Q, Petersen DR, Ware JA, Piccotti JR, Kawabata TT, Ju C (2008) Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Mol Pharmacol 73:1769\u20131775","journal-title":"Mol Pharmacol"},{"key":"530_CR5","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1074\/jbc.275.5.3693","volume":"275","author":"J Choi","year":"2000","unstructured":"Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, Forman HJ (2000) Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J Biol Chem 275:3693\u20133698","journal-title":"J Biol Chem"},{"key":"530_CR6","first-page":"103","volume-title":"Nutrient requirements of the guinea pig. Nutrient requirements of laboratory animals","author":"NR Council","year":"1995","unstructured":"Council NR (1995) Nutrient requirements of the guinea pig. Nutrient requirements of laboratory animals. National Academies Press, Washington, pp 103\u2013124"},{"key":"530_CR7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0090-9556(25)08652-0","volume":"18","author":"AE Cribb","year":"1990","unstructured":"Cribb AE, Spielberg SP (1990) Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. Drug Metab Dispos 18:784\u2013787","journal-title":"Drug Metab Dispos"},{"key":"530_CR8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","volume":"19","author":"AE Cribb","year":"1991","unstructured":"Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP (1991) Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Drug Metab Dispos 19:900\u2013906","journal-title":"Drug Metab Dispos"},{"key":"530_CR9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1515\/bchm2.1973.354.1.555","volume":"354","author":"E Degkwitz","year":"1973","unstructured":"Degkwitz E, Kim KS (1973) Comparative studies on the influence of l-ascorbate, d-arabino-ascorbate and 5-oxo-d-gluconate on the amounts of cytochromes P-450 and b5 in liver microsomes of guinea pigs. Hoppe Seylers Z Physiol Chem 354:555\u2013561","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"530_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000459386","volume":"16","author":"E Degkwitz","year":"1973","unstructured":"Degkwitz E, Walsch S, Dubberstein M, Winter J (1973) Influence of L-ascorbate on the contents of cytochromes P-450 and b5 in several organs of guinea pigs. Enzyme 16:237\u2013245","journal-title":"Enzyme"},{"key":"530_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/08892220252779629","volume":"18","author":"AG DiRienzo","year":"2002","unstructured":"DiRienzo AG, van der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT (2002) Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. AIDS Res Hum Retroviruses 18:89\u201394","journal-title":"AIDS Res Hum Retroviruses"},{"key":"530_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.103.050112","volume":"306","author":"J Farrell","year":"2003","unstructured":"Farrell J, Naisbitt DJ, Drummond NS, Depta JP, Vilar FJ, Pirmohamed M, Park BK (2003) Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther 306:229\u2013237","journal-title":"J Pharmacol Exp Ther"},{"key":"530_CR13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","volume":"340","author":"H Furrer","year":"1999","unstructured":"Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel B, Battegay M, Telenti A, Vernazza P, Rickenbach M, Flepp M, Malinverni R (1999) Discontinuation of primary prophylaxis against PCP in HIV1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med 340:1301\u20131306","journal-title":"N Engl J Med"},{"key":"530_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(24)36867-3","volume":"282","author":"HJ Gill","year":"1997","unstructured":"Gill HJ, Hough SJ, Naisbitt DJ, Maggs JL, Kitteringham NR, Pirmohamed M, Park BK (1997) The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. J Pharmacol Exp Ther 282:795\u2013801","journal-title":"J Pharmacol Exp Ther"},{"key":"530_CR15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archinte.162.8.921","volume":"162","author":"S Goldie","year":"2002","unstructured":"Goldie S, Kaplan J, Losina E, Weinstein M, Paltiel A, Seage G, Craven D, Kimmel A, Zhang H, Cohen C, Freedberg K (2002) Prophylaxis for human immunodeficiency virus-related Pneumocystis carnii pneumonia. Arch Intern Med 162:921\u2013928","journal-title":"Arch Intern Med"},{"key":"530_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","volume":"100","author":"FM Gordin","year":"1984","unstructured":"Gordin FM, Simon GL, Wofsy CB, Mills J (1984) Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100:495\u2013499","journal-title":"Ann Intern Med"},{"key":"530_CR17","first-page":"209","volume":"73","author":"OW Griffith","year":"1999","unstructured":"Griffith OW, Mulcahy RT (1999) The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Relat Areas Mol Biol 73:209\u2013267 (xii)","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"530_CR18","first-page":"CD003108","volume":"3","author":"K Grimwade","year":"2003","unstructured":"Grimwade K, Swingler G (2003) Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. Cochrane Database Syst Rev 3:CD003108","journal-title":"Cochrane Database Syst Rev"},{"key":"530_CR19","first-page":"E205","volume":"276","author":"F Jahoor","year":"1999","unstructured":"Jahoor F, Jackson A, Gazzard B, Philips G, Sharpstone D, Frazer ME, Heird W (1999) Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. Am J Physiol 276:E205\u2013E211","journal-title":"Am J Physiol"},{"key":"530_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinids\/4.2.426","volume":"4","author":"H Jick","year":"1982","unstructured":"Jick H (1982) Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 4:426\u2013428","journal-title":"Rev Infect Dis"},{"key":"530_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1971.00310210075006","volume":"128","author":"J Koch-Weser","year":"1971","unstructured":"Koch-Weser J, Sidel VW, Dexter M, Parish C, Finer DC, Kanarek P (1971) Adverse reactions to sulfosoxazole, sulfamethoxazole, and nitrofurantoin. Manifestations and specific reaction rates during 2, 118 courses of therapy. Arch Intern Med 128:399\u2013404","journal-title":"Arch Intern Med"},{"key":"530_CR22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/jpet.104.072389","volume":"311","author":"JR Kurian","year":"2004","unstructured":"Kurian JR, Bajad SU, Miller JL, Chin NA, Trepanier LA (2004) NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther 311:1171\u20131178","journal-title":"J Pharmacol Exp Ther"},{"key":"530_CR23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/153537020122600910","volume":"226","author":"CA Lang","year":"2001","unstructured":"Lang CA, Huang A, Ramirez JA, Liu MC (2001) Erythrocytic glutathione and plasma cysteine status of human immunodeficient patients. Exp Biol Med (Maywood) 226:866\u2013869","journal-title":"Exp Biol Med (Maywood)"},{"key":"530_CR24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2222.2006.02506.x","volume":"36","author":"SN Lavergne","year":"2006","unstructured":"Lavergne SN, Danhof RS, Volkman EM, Trepanier LA (2006) Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity. Clin Exp Allergy 36:907\u2013915","journal-title":"Clin Exp Allergy"},{"key":"530_CR25","doi-asserted-by":"crossref","unstructured":"Lavergne SN, Wang H, Callan HE, Park BK, Naisbitt DJ (2009) \u201cDanger\u201d conditions increase sulfamethoxazole-protein adduct formation in human antigen presenting cells. J Pharmacol Exp Ther [Epub ahead of print]","DOI":"10.1124\/jpet.109.155374"},{"key":"530_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"530_CR27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/mol.62.5.1011","volume":"62","author":"T Manchanda","year":"2002","unstructured":"Manchanda T, Hess D, Dale L, Ferguson SG, Rieder MJ (2002) Haptenation of sulfonamide reactive metabolites to cellular proteins. Mol Pharmacol 62:1011\u20131026","journal-title":"Mol Pharmacol"},{"key":"530_CR28","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.88.11.4656","volume":"88","author":"J Martensson","year":"1991","unstructured":"Martensson J, Meister A (1991) Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc Natl Acad Sci U S A 88:4656\u20134660","journal-title":"Proc Natl Acad Sci U S A"},{"key":"530_CR29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","volume":"323","author":"I Medina","year":"1990","unstructured":"Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, Benowitz N, Wofsy CB (1990) Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 323:776\u2013782","journal-title":"N Engl J Med"},{"key":"530_CR30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","volume":"126","author":"DJ Naisbitt","year":"1999","unstructured":"Naisbitt DJ, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, Park BK (1999) Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 126:1393\u20131407","journal-title":"Br J Pharmacol"},{"key":"530_CR31","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/088922200750054657","volume":"16","author":"DJ Naisbitt","year":"2000","unstructured":"Naisbitt DJ, Vilar FJ, Stalford AC, Wilkins EG, Pirmohamed M, Park BK (2000) Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses 16:1929\u20131938","journal-title":"AIDS Res Hum Retroviruses"},{"key":"530_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","volume":"133","author":"DJ Naisbitt","year":"2001","unstructured":"Naisbitt DJ, Gordon SF, Pirmohamed M, Burkhart C, Cribb AE, Pichler WJ, Park BK (2001) Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol 133:295\u2013305","journal-title":"Br J Pharmacol"},{"key":"530_CR33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","volume":"62","author":"DJ Naisbitt","year":"2002","unstructured":"Naisbitt DJ, Farrell J, Gordon SF, Maggs JL, Burkhart C, Pichler WJ, Pirmohamed M, Park BK (2002) Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol Pharmacol 62:628\u2013637","journal-title":"Mol Pharmacol"},{"key":"530_CR34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/003655401317074581","volume":"33","author":"C Rabaud","year":"2001","unstructured":"Rabaud C, Charreau I, Izard S, Raffi F, Meiffredy V, Leport C, Guillemin F, Veni P, Aboulker J, Delta trial group (2001) Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression. Scand J Infect Dis 33:759\u2013764","journal-title":"Scand J Infect Dis"},{"key":"530_CR35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.00985.x","volume":"114","author":"TP Reilly","year":"2000","unstructured":"Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, Svensson CK (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 114:1164\u20131173","journal-title":"J Invest Dermatol"},{"key":"530_CR36","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.178.9.5533","volume":"178","author":"JP Sanderson","year":"2007","unstructured":"Sanderson JP, Naisbitt DJ, Farrell J, Ashby CA, Tucker MJ, Rieder MJ, Pirmohamed M, Clarke SE, Park BK (2007) Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 178:5533\u20135542","journal-title":"J Immunol"},{"key":"530_CR37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00126334-200408150-00007","volume":"36","author":"LA Trepanier","year":"2004","unstructured":"Trepanier LA, Yoder AR, Bajad S, Beckwith MD, Bellehumeur JL, Graziano FM (2004) Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection. J Acquir Immune Defic Syndr 36:1041\u20131050","journal-title":"J Acquir Immune Defic Syndr"},{"key":"530_CR38","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/00002030-199714000-00005","volume":"11","author":"SL Walmsley","year":"1997","unstructured":"Walmsley SL, Winn LM, Harrison ML, Uetrecht JP, Wells PG (1997) Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications. Aids 11:1689\u20131697","journal-title":"Aids"},{"key":"530_CR39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00042560-199812150-00009","volume":"19","author":"SL Walmsley","year":"1998","unstructured":"Walmsley SL, Khorasheh S, Singer J, Djurdjev O (1998) A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). J Acquir Immunodefic Syndr Human Retrovirol 19:498\u2013505","journal-title":"J Acquir Immunodefic Syndr Human Retrovirol"},{"key":"530_CR40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0360-3016(84)90330-4","volume":"10","author":"NY Yu","year":"1984","unstructured":"Yu NY, Brown JM (1984) Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508. Int J Radiat Oncol Biol Phys 10:1265\u20131269","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-010-0530-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-010-0530-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-010-0530-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:48:25Z","timestamp":1739962105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-010-0530-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1007\/s00204-010-0530-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2010,3,11]]}}}